Esther Vazquez
About Esther Vazquez
Esther Vazquez is the PSP Sr Manager Hematologia at Bristol Myers Squibb and holds multiple roles at Celgene in Mexico, with extensive experience in social programs and patient support initiatives.
Title and Current Positions
Esther Vazquez holds the position of PSP Sr Manager Hematologia at Bristol Myers Squibb in Mexico. Additionally, she serves in dual roles at Celgene as Soporte al Paciente and Advocacy Sr. Manager for PSP in Mexico.
Education and Expertise
Esther Vazquez has a robust educational background, highlighted by her Master in Corporate Social Responsibility from Barcelona University's ESERP Business School, completed from 2011 to 2012. She also holds a degree in Cirujano Dentista from UNAM, Ciudad de México, achieved between 1980 and 1983. Furthermore, she attended a Sales to Government Course in 2017. These qualifications have equipped her with extensive knowledge in business, corporate social responsibility, and healthcare.
Professional Background
With an extensive 22-year career, Esther Vazquez has worked with nonprofit civil international organizations. Her focus has been on strategic planning, institutional strengthening, financial self-sustainability, and fundraising training. Her rich experience spans various social programs across Latin America and the Caribbean.
Initiatives and Leadership
Esther Vazquez has played a critical role in developing and managing diagnosis, monitoring, and adherence programs for orphan drugs. She has been instrumental in strategic alliances with both national and international networks. Additionally, she has spearheaded efforts in legislative forums, patient rights training, and public relations campaigns. She has also contributed significantly to projects related to Seguro Popular – INSABI, particularly those addressing catastrophic diseases.
Management of Patient Programs
Esther Vazquez has vast experience managing 'Free of Charge' programs for patients. Her leadership in this area has ensured that patients have access to necessary medications and treatments without financial burden. This initiative underscores her commitment to patient advocacy and healthcare accessibility.